SCHEMBL7299247

SCHEMBL7299247

[c]1ccccc1Oc1ccc(-c2cccs2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.41
KCNH2 Q12809 2/20 0.40
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
HRH3 Q9Y5N1 1/20 0.38
CYP17A1 P05093 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
BTK Q06187 1/20 0.37
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 3/20 0.35
LPL P06858 1/20 0.35
LIPG Q9Y5X9 1/20 0.35
ICAM1 P05362 1/20 0.34
SELE P16581 1/20 0.34
VCAM1 P19320 1/20 0.34
CYP2E1 P05181 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2A6 P11509 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9796767 0.79 LTA4H (0.55) LTA4HKCNH2PPARGPPARAHRH3
SCHEMBL7309519 0.79 DYRK1A (0.36) LTA4HALDH1A1KDM4EMAPTNPC1
SCHEMBL5641149 0.78 LTA4H (0.50) LTA4HKCNH2PPARGPPARAHRH3
SCHEMBL9672822 0.78 GSTP1 (0.37) LTA4HALDH1A1KMT2ACYP2C9NPC1
SCHEMBL7299255 0.77 LTA4H (0.46) LTA4HKCNH2PPARGPPARAHRH3
SCHEMBL7300800 0.76 CYP2A6 (0.48) LTA4HKCNH2CYP17A1CYP11B1CYP11B2
SCHEMBL8535180 0.74 LTA4H (0.52) LTA4HKMT2ANPC1RAB9AMEN1
SCHEMBL76698 0.73 LTA4H (0.50) LTA4HKMT2AKDM4EMAPT
SCHEMBL4720797 0.73 MGMT (0.31)
Water SCHEMBL27530954 0.72 LTA4H (0.48) LTA4HKMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP claimed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US claimed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP claimed
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed